Organism name | Vicia faba |
---|---|
Genus | Vicia |
Family | Fabaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Vicia faba |
---|---|
Linked NCBI taxonomy ID | 3906 |
Linked level | species |
Family in NCBI taxonomy | Fabaceae |
---|---|
ID | 3803 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00007247
![]() |
Linolenic acid
/ alpha-Linolenic acid / (Z,Z,Z)-Octadeca-9,12,15-trienoic acid |
D017962
|
22 / 5 |
![]() |
||||
C00005981
![]() |
Quercetin 3-(6''-acetylgalactoside)-7-rhamnoside
|
No. 1 | No. 15 |
![]() |
||||
C00005888
![]() |
Kaempferol 3-(6''-acetylgalactoside)-7-rhamnoside
|
No. 1 | No. 15 |
![]() |
||||
C00005178
![]() |
Kaempferol 3-galactoside-7-rhamnoside
|
CHEMBL1929192
CHEMBL1929193 |
2 / 0 / 0 | No. 1 | No. 15 |
![]() |
||
C00005425
![]() |
Quercetin 3-galactoside-7-rhamnoside
|
CHEMBL592361
CHEMBL1774171 |
No. 1 | No. 15 |
![]() |
|||
C00005408
![]() |
Quercetin 3-galactosyl-(1->6)-glucoside
|
CHEMBL1097317
|
No. 1 | No. 15 |
![]() |
|||
C00005184
![]() |
Kaempferol 3-glucoside-7-rhamnoside
|
CHEMBL1929192
CHEMBL1929193 |
2 / 0 / 0 | No. 1 | No. 15 |
![]() |
||
C00005182
![]() |
Kaempferol 3,7-diglucoside
/ Kaempferol 3,7-O-beta-D-diglucopyranoside |
CHEMBL2206209
|
No. 1 | No. 15 |
![]() |
|||
C00001071
![]() |
Myricetin
|
CHEMBL164
|
C040015
|
78 / 70 / 56 | 39 / 2 | No. 3 | No. 15 |
![]() |
C00005906
![]() |
Kaempferol 3-rhamnosyl-(1->2)(6''-acetylgalactoside)-7-rhamnoside
|
No. 5 | No. 15 |
![]() |
||||
C00005224
![]() |
Kaempferol 3-rhamnosyl-(1->2)-galactoside-7-rhamnoside
|
CHEMBL1929027
CHEMBL1926685 |
2 / 0 / 0 | No. 5 | No. 15 |
![]() |
||
C00009075
![]() |
Procyanidin B1
/ Epicatechin-(4beta->8)-catechin |
CHEMBL38714
CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 |
C479579
|
20 / 7 / 8 | No. 16 | No. 19 |
![]() |
|
C00002935
![]() |
Procyanidin B4
/ Catechin-(4alpha->8)-epicatechin |
CHEMBL38714
CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 |
20 / 7 / 8 | No. 16 | No. 19 |
![]() |
||
C00002923
![]() |
Prodelphinidin B4
/ Gallocatechin-(4alpha->8)-epigallocatechin |
CHEMBL349509
CHEMBL161013 |
No. 16 | No. 19 |
![]() |
|||
C00009111
![]() |
Prodelphinidin C
|
No. 16 | No. 19 |
![]() |
||||
C00009112
![]() |
Gallocatechin-(4alpha->8)-epicatechin
|
No. 16 | No. 19 |
![]() |
||||
C00000299
![]() |
GA98
/ Gibberellin A98 |
No. 40 | No. 41 |
![]() |
||||
C00000020
![]() |
GA20
/ Gibberellin A20 |
No. 40 | No. 41 |
![]() |
||||
C00000044
![]() |
GA44
/ Gibberellin A44 |
No. 40 | No. 41 |
![]() |
||||
C00000029
![]() |
GA29
/ Gibberellin A29 |
No. 40 | No. 41 |
![]() |
||||
C00008818
![]() |
Epigallocatechin
/ (-)-Epigallocatechin |
CHEMBL47386
CHEMBL125743 CHEMBL130415 CHEMBL264167 CHEMBL404845 |
26 / 17 / 29 | No. 52 | No. 14 |
![]() |
||
C00000956
![]() |
(-)-Epicatechin
|
CHEMBL80941
CHEMBL311498 CHEMBL129482 CHEMBL200715 CHEMBL206452 CHEMBL583912 |
85 / 58 / 54 | No. 52 | No. 14 |
![]() |
||
C00000181
![]() |
Castasterone
|
C083545
|
No. 68 | No. 11 |
![]() |
|||
C00000180
![]() |
24-Epibrassinolide
|
CHEMBL563853
CHEMBL1801925 CHEMBL1967970 |
No. 68 | No. 11 |
![]() |
|||
C00000189
![]() |
Brassinone
/ Norcastasterone / 28-Norcastasterone |
No. 68 | No. 11 |
![]() |
||||
C00000192
![]() |
Dolichosterone
|
No. 68 | No. 11 |
![]() |
||||
C00000176
![]() |
Brassinolide
|
CHEMBL563853
CHEMBL1801925 CHEMBL1967970 |
C023623
|
16 / 2 | No. 68 | No. 11 |
![]() |
|
C00003825
![]() |
3',4',7-Trihydroxyflavone
/ 7,3',4'-Trihydroxyflavone |
CHEMBL301624
|
4 / 5 / 5 | No. 71 | No. 15 |
![]() |
||
C00003800
![]() |
7,4'-Dihydroxyflavone
|
CHEMBL294878
|
C085172
|
17 / 19 / 16 | No. 76 | No. 15 |
![]() |
|
C00000019
![]() |
GA19
/ Gibberellin A19 |
C120175
|
No. 187 | No. 41 |
![]() |
|||
C00000053
![]() |
GA53
/ Gibberellin A53 |
No. 187 | No. 41 |
![]() |
||||
C00000225
![]() |
9,10-Dihydrojasmonic acid
|
No. 707 | No. 70 |
![]() |
||||
C00000218
![]() |
Jasmonic acid
/ trans-Jasmonic acid / 3-Oxo-2-(2Z-pentenyl)cyclotentylacetic acid |
CHEMBL445499
CHEMBL449572 |
C011006
|
4 / 1 / 0 | No. 707 | No. 70 |
![]() |
|
C00000362
![]() |
OPC-6:0
|
No. 707 | No. 70 |
![]() |
||||
C00000134
![]() |
(s)-(+)-Abscisic acid
/ 2,4-Pentadienoic acid |
CHEMBL288040
CHEMBL379808 CHEMBL1318134 CHEMBL1469719 CHEMBL1741460 CHEMBL1965138 |
D000040
|
10 / 9 / 10 | No. 1435 | No. 38 |
![]() |
|
C00011540
![]() |
Nigellic acid
|
CHEMBL396834
|
No. 1435 | No. 38 |
![]() |
|||
C00001357
![]() |
L-Dopa
|
CHEMBL1009
CHEMBL351042 CHEMBL211670 |
140 / 68 / 62 | No. 1584 |
![]() |
|||
C00001145
![]() |
Raffinose
|
CHEMBL175500
CHEMBL603717 |
D011887
|
No. 1765 |
![]() |
|||
C00001518
![]() |
L-Glutathione
|
CHEMBL100476
CHEMBL1543 CHEMBL1514919 |
D005978
|
12 / 17 / 16 | 119 / 45 | No. 3357 |
![]() |
|
C00000447
![]() |
4-Hydroxy-2E-nonenal
|
CHEMBL454280
|
4 / 7 / 6 | No. 3536 |
![]() |
|||
C00001201
![]() |
Quinic acid
|
CHEMBL444501
CHEMBL465398 |
D011801
|
5 / 1 / 3 | No. 3541 |
![]() |
||
C00001183
![]() |
Fumaric acid
|
CHEMBL503160
CHEMBL539648 |
C032005
|
17 / 14 / 46 | 0 / 1 | No. 3766 |
![]() |
|
C00000103
![]() |
4-Chloroindole-3-acetic acid methyl ester
|
C028267
|
No. 4225 |
![]() |
||||
C00000102
![]() |
4-Chloro-IAA
/ 4-Chloroindole-3-acetic acid |
CHEMBL309993
|
C096198
|
1 / 0 / 0 | No. 4225 |
![]() |
||
C00001515
![]() |
Vicine
|
C009661
|
No. 4434 |
![]() |
||||
C00001299
![]() |
Wyerone
|
No. 5575 | No. 69 |
![]() |
||||
C00001300
![]() |
Wyerone acid
|
No. 5575 | No. 69 |
![]() |
||||
C00001431
![]() |
Spermidine
|
CHEMBL19612
|
D013095
|
26 / 10 / 12 | 5 / 5 | No. 5867 |
![]() |
|
C00001432
![]() |
Spermine
|
CHEMBL23194
|
D013096
|
35 / 17 / 25 | 7 / 11 | No. 7197 |
![]() |
|
C00001198
![]() |
Oxalic acid
|
CHEMBL146755
|
D019815
|
2 / 0 / 0 | 1 / 6 | No. 7540 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000134 C00000956 C00001071 C00001357 C00001431 C00001432 C00002935 C00003800 C00009075 | 0 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000956 C00001071 C00001357 C00001431 C00001432 C00001518 C00002935 C00008818 C00009075 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000134 C00000956 C00001071 C00001357 C00001431 C00001432 C00002935 C00009075 | 1 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000134 C00000956 C00001071 C00001357 C00001431 C00001432 C00002935 C00009075 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000134 C00000956 C00001071 C00001357 C00001431 C00001432 C00002935 C00009075 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000134 C00000956 C00001071 C00001357 C00001431 C00001432 C00002935 C00009075 | 0 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000956 C00001071 C00001357 C00001432 C00002935 C00003800 C00008818 C00009075 | 3 / 3 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000956 C00001071 C00001357 C00001518 C00003800 C00008818 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000956 C00001183 C00001357 C00001431 C00001432 C00001518 | 1 / 2 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000447 C00000956 C00001071 C00001357 C00001518 C00008818 | 4 / 3 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000956 C00001183 C00001357 C00001431 C00001432 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00000956 C00001071 C00005178 C00005184 C00005224 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000447 C00000956 C00001071 C00001357 C00008818 | 2 / 3 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000956 C00001183 C00001357 C00001431 C00001432 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000956 C00001071 C00001357 C00001432 C00008818 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000956 C00001071 C00001357 C00003800 C00008818 | 2 / 2 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000956 C00001071 C00001357 C00001431 C00001432 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000956 C00001071 C00001201 C00001357 C00008818 | 0 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000956 C00001071 C00001357 C00003800 C00008818 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000956 C00001071 C00001183 C00001357 C00008818 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000956 C00001183 C00001357 C00001431 C00001432 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001071 C00001183 C00001201 C00001357 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001071 C00001357 C00001432 C00008818 | 1 / 4 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000956 C00001357 C00001431 C00001432 | 1 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001071 C00001357 C00001432 C00008818 | 0 / 1 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000956 C00001357 C00001431 C00001432 | 1 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000956 C00001071 C00001357 C00008818 | 1 / 1 |
O75496 | Geminin | Unclassified protein | C00001183 C00001201 C00001357 C00001518 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000956 C00001357 C00001431 C00001432 | 0 / 1 |
P11387 | DNA topoisomerase 1 | Isomerase | C00001071 C00005178 C00005184 C00005224 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000956 C00001357 C00001431 C00001432 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000956 C00001357 C00001431 C00001432 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000956 C00001071 C00001357 C00001432 | 1 / 2 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000956 C00001357 C00001431 C00001432 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000956 C00001357 C00002935 C00009075 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000956 C00001071 C00001357 C00008818 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000134 C00000956 C00001183 C00001431 | 3 / 2 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000956 C00001357 C00001431 C00001432 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00000956 C00001071 C00001357 C00001432 | 2 / 5 |
P39748 | Flap endonuclease 1 | Enzyme | C00000956 C00001071 C00001357 | 0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000956 C00001357 C00008818 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00000956 C00001071 C00001357 | 1 / 1 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001071 C00001431 C00001432 | 0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00000956 C00001071 C00003800 | 0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00000956 C00002935 C00009075 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000134 C00001183 C00001357 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001071 C00001183 C00001357 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00000956 C00002935 C00009075 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000956 C00001071 C00008818 | 1 / 1 |
P40225 | Thrombopoietin | Unclassified protein | C00001071 C00001431 C00001432 | 1 / 1 |
P06746 | DNA polymerase beta | Enzyme | C00000956 C00001071 C00001357 | 0 / 0 |
Q05513 | Protein kinase C zeta type | Iota | C00000956 C00002935 C00009075 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00000956 C00002935 C00009075 | 0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00000956 C00001071 C00001357 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000956 C00001357 C00008818 | 0 / 0 |
Q02156 | Protein kinase C epsilon type | Eta | C00000956 C00002935 C00009075 | 0 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00000956 C00002935 C00009075 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000956 C00001357 C00008818 | 0 / 0 |
P41743 | Protein kinase C iota type | Iota | C00000956 C00002935 C00009075 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000956 C00001357 C00008818 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00000956 C00002935 C00009075 | 1 / 0 |
P02768 | Serum albumin | Secreted protein | C00000102 C00000956 C00008818 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000956 C00001357 C00003800 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00000956 C00001071 C00001357 | 1 / 2 |
P05771 | Protein kinase C beta type | Alpha | C00000956 C00002935 C00009075 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00000956 C00002935 C00009075 | 1 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001071 C00001357 C00001432 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000956 C00001071 C00008818 | 0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001071 C00001518 | 1 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000956 C00001071 | 5 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | C00001071 C00001357 | 1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001183 C00001431 | 0 / 0 |
P56817 | Beta-secretase 1 | A1A | C00000956 C00008818 | 0 / 0 |
P00374 | Dihydrofolate reductase | Oxidoreductase | C00000956 C00008818 | 1 / 1 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00000956 C00001071 | 0 / 1 |
P03372 | Estrogen receptor | NR3A1 | C00000134 C00001357 | 1 / 1 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00000956 C00008818 | 2 / 3 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000956 C00001071 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00001071 C00001357 | 1 / 0 |
P23467 | Receptor-type tyrosine-protein phosphatase beta | Receptor tyrosine-protein phosphatase | C00002935 C00009075 | 0 / 0 |
P18433 | Receptor-type tyrosine-protein phosphatase alpha | Receptor tyrosine-protein phosphatase | C00002935 C00009075 | 0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001357 C00003800 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00001071 C00001357 | 2 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001357 C00003800 | 1 / 1 |
P04745 | Alpha-amylase 1 | Enzyme | C00000956 C00001071 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001071 C00003800 | 2 / 2 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00000956 C00003800 | 4 / 1 |
P52209 | 6-phosphogluconate dehydrogenase, decarboxylating | Enzyme | C00000956 C00008818 | 0 / 0 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001071 C00001357 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00001071 C00001357 | 0 / 0 |
P10415 | Apoptosis regulator Bcl-2 | Other cytosolic protein | C00000956 C00008818 | 0 / 7 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00000956 C00001071 | 3 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00001357 C00003800 | 0 / 1 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00000956 C00001071 | 0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00000956 C00001071 | 0 / 1 |
Q9H015 | Solute carrier family 22 member 4 | Unclassified protein | C00001431 C00001432 | 1 / 1 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001071 C00001357 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001071 C00001357 | 2 / 1 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00001071 C00001518 | 0 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00001071 C00001518 | 0 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001071 C00001431 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001071 C00001357 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001071 C00001357 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001357 | 1 / 1 |
P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000218 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001431 | 0 / 0 |
P07998 | Ribonuclease pancreatic | Enzyme | C00000956 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00001357 | 1 / 1 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000956 | 2 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001357 | 0 / 0 |
O15439 | Multidrug resistance-associated protein 4 | Unclassified protein | C00001518 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001357 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00001357 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00001357 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001357 | 1 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00001071 | 1 / 1 |
Q92731 | Estrogen receptor beta | NR3A2 | C00001357 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001357 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00001071 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00001357 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001357 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00000134 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001357 | 1 / 0 |
P16581 | E-selectin | Adhesion | C00001201 | 0 / 0 |
Q14790 | Caspase-8 | C14 | C00001071 | 2 / 1 |
Q6QHF9 | Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | Enzyme | C00001431 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001357 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00001357 | 0 / 0 |
P07711 | Cathepsin L1 | C1A | C00000956 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001357 | 1 / 0 |
P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | C00003825 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00001357 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001357 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001357 | 1 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001357 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001357 | 1 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001071 | 0 / 0 |
P11308 | Transcriptional regulator ERG | Unclassified protein | C00001183 | 1 / 2 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001357 | 0 / 0 |
Q15746 | Myosin light chain kinase, smooth muscle | Mlck | C00001071 | 1 / 1 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00001071 | 0 / 0 |
P42575 | Caspase-2 | C14 | C00001432 | 0 / 0 |
P00734 | Prothrombin | S1A | C00000956 | 4 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | C00001357 | 0 / 1 |
P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | C00001071 | 5 / 4 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001357 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001357 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00001357 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00001357 | 4 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001357 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001357 | 2 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00003800 | 5 / 3 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001357 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001357 | 1 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00001071 | 4 / 4 |
P21452 | Substance-K receptor | Neurokinin receptor | C00001357 | 0 / 0 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00001198 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00001071 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001357 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001357 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001357 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00003800 | 1 / 1 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001357 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001357 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001357 | 2 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001357 | 1 / 8 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001357 | 1 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001071 | 1 / 0 |
Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | C00001071 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001357 | 2 / 1 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00001183 | 1 / 1 |
Q12879 | Glutamate receptor ionotropic, NMDA 2A | NS | C00001432 | 0 / 0 |
Q05586 | Glutamate receptor ionotropic, NMDA 1 | NS | C00001432 | 1 / 0 |
Q9Y2Q3 | Glutathione S-transferase kappa 1 | Enzyme | C00001518 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001357 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00001357 | 0 / 0 |
O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00000447 | 1 / 0 |
Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000218 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001357 | 0 / 0 |
P49327 | Fatty acid synthase | Transferase | C00000956 | 0 / 0 |
O15217 | Glutathione S-transferase A4 | Enzyme | C00000447 | 0 / 0 |
Q9H2K2 | Tankyrase-2 | Enzyme | C00003825 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001357 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00001071 | 0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00001071 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001357 | 1 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001357 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001357 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001357 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00001357 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00001357 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001357 | 0 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001357 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000956 | 0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00001071 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001357 | 1 / 0 |
P55210 | Caspase-7 | C14 | C00001357 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00001201 | 1 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00001357 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00001357 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001357 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 1 |
Q15046 | Lysine--tRNA ligase | Enzyme | C00001071 | 2 / 1 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00000956 | 1 / 0 |
P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000218 | 1 / 0 |
P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | C00003800 | 1 / 1 |
P42574 | Caspase-3 | C14 | C00001432 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000956 | 5 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001357 | 3 / 1 |
Q8TD43 | Transient receptor potential cation channel subfamily M member 4 | Unclassified protein | C00001432 | 1 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00001518 | 11 / 10 |
P10275 | Androgen receptor | NR3C4 | C00000134 | 3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001357 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00001357 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00003800 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 0 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00001183 | 0 / 0 |
O95271 | Tankyrase-1 | Enzyme | C00003825 | 0 / 0 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001357 | 0 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00000956 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001357 | 0 / 0 |
O14746 | Telomerase reverse transcriptase | Enzyme | C00003825 | 5 / 5 |
P14780 | Matrix metalloproteinase-9 | M10A | C00001357 | 2 / 2 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00003800 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00001357 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00001357 | 0 / 0 |
P42336 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Enzyme | C00001071 | 9 / 1 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000956 | 1 / 1 |
P04062 | Glucosylceramidase | Enzyme | C00001071 | 6 / 4 |
P46059 | Solute carrier family 15 member 1 | Dipeptide | C00001357 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001357 | 0 / 0 |
P61073 | C-X-C chemokine receptor type 4 | CXC chemokine receptor | C00001432 | 1 / 1 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001357 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000956 | 3 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001357 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00001357 | 2 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001357 | 2 / 2 |
Q16798 | NADP-dependent malic enzyme, mitochondrial | Enzyme | C00001183 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001071 | 2 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00001198 | 0 / 0 |
P31941 | DNA dC->dU-editing enzyme APOBEC-3A | Enzyme | C00001071 | 0 / 0 |
Q9NZQ8 | Transient receptor potential cation channel subfamily M member 5 | Unclassified protein | C00001432 | 0 / 0 |
P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000218 | 1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001183 | 7 / 37 |
Q96QA9 | Multidrug resistance associated protein | Unclassified protein | C00001518 | 0 / 0 |
Q05BR4 | SLC16A10 protein | Unclassified protein | C00001357 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000956 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00000956 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000956 | 3 / 0 |
Q9C0B1 | Alpha-ketoglutarate-dependent dioxygenase FTO | Unclassified protein | C00001183 | 1 / 2 |
Q9HCT0 | Fibroblast growth factor 22 | Unclassified protein | C00001071 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000176
C00001071
C00001432
C00001518
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000176
C00001071
C00001431
C00001518
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00001071
C00001518
C00007247
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001071
C00001518
C00007247
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00001071
C00001518
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000176
C00001518
|
153 | ADRB1, ADRB1R, B1AR, BETA1AR, RHR | adrenoceptor beta 1 |
C00001431
C00001432
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00001431
C00001518
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001432
C00001518
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000176
C00001071
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00001432
C00001518
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00001518
C00007247
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00001518
C00007247
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00001518
C00007247
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000176
C00001518
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000176
C00001518
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00001071
C00001518
|
891 | CCNB1, CCNB | cyclin B1 |
C00000176
C00001071
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001518
C00007247
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001071
C00001518
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00001071
C00001518
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00001518
C00007247
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00001518
C00007247
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00001071
C00001518
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001071
C00001518
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00001071
C00001518
|
154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00001431
C00001432
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001071
C00001518
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001071
C00001518
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00001071
C00001518
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00001071
C00001518
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00001071
C00001518
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00001071
C00001518
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00000176
C00001518
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001071
C00001518
|
5757 | PTMA, TMSA | prothymosin, alpha |
C00001518
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00001071
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00001071
|
54583 | EGLN1, C1orf12, ECYT3, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2, SM20, ZMYND6 | egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) |
C00001071
|
8505 | PARG, PARG99 | poly (ADP-ribose) glycohydrolase (EC:3.2.1.143) |
C00001071
|
1786 | DNMT1, ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT | DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) |
C00001071
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00001071
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001071
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00001071
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00001071
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00001071
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00001071
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00001071
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00001071
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00001071
|
7161 | TP73, P73 | tumor protein p73 |
C00001071
|
8714 | ABCC3, ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
C00001518
|
10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00001518
|
10057 | ABCC5, ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP, pABC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
C00001518
|
368 | ABCC6, ABC34, ARA, EST349056, GACI2, MLP1, MOAT-E, MOATE, MRP6, PXE, PXE1, URG7 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
C00001518
|
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00001518
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00001518
|
8574 | AKR7A2, AFAR, AFAR1, AFB1-AR1, AKR7 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (EC:1.1.1.n11) |
C00001518
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00001518
|
57412 | AS3MT, CYT19 | arsenic (+3 oxidation state) methyltransferase (EC:2.1.1.137) |
C00001518
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00001518
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00001518
|
648 | BMI1, FLVI2/BMI1, PCGF4, RNF51 | BMI1 polycomb ring finger oncogene |
C00001518
|
6364 | CCL20, CKb4, LARC, MIP-3-alpha, MIP-3a, MIP3A, SCYA20, ST38 | chemokine (C-C motif) ligand 20 |
C00001518
|
942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00001518
|
994 | CDC25B | cell division cycle 25B (EC:3.1.3.48) |
C00001518
|
995 | CDC25C, CDC25, PPP1R60 | cell division cycle 25C (EC:3.1.3.48) |
C00001518
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001518
|
1270 | CNTF, HCNTF | ciliary neurotrophic factor |
C00001518
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00001071
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00001518
|
847 | CAT | catalase (EC:1.11.1.6) |
C00001071
|
397 | ARHGDIB, D4, GDIA2, GDID4, LYGDI, Ly-GDI, RAP1GN1, RhoGDI2 | Rho GDP dissociation inhibitor (GDI) beta |
C00001071
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00001518
|
1673 | DEFB4A, BD-2, DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1 | defensin, beta 4A |
C00001518
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00001518
|
2056 | EPO, EP, MVCD2 | erythropoietin |
C00001518
|
14103 |
C00001518
|
||
2495 | FTH1, FHC, FTH, FTHL6, PIG15, PLIF | ferritin, heavy polypeptide 1 (EC:1.16.3.1) |
C00001518
|
2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00001518
|
2597 | GAPDH, G3PD, GAPD | glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12) |
C00001518
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00000176
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00001518
|
2745 | GLRX, GRX, GRX1 | glutaredoxin (thioltransferase) (EC:1.8.4.1) |
C00001518
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00001518
|
2937 | GSS, GSHS | glutathione synthetase (EC:6.3.2.3) |
C00001518
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00001518
|
2939 | GSTA2, GST2, GSTA2-2, GTA2, GTH2 | glutathione S-transferase alpha 2 (EC:2.5.1.18) |
C00001518
|
2940 | GSTA3, GSTA3-3, GTA3 | glutathione S-transferase alpha 3 (EC:2.5.1.18) |
C00001518
|
2941 | GSTA4, GSTA4-4, GTA4 | glutathione S-transferase alpha 4 (EC:2.5.1.18) |
C00001518
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00001518
|
2946 | GSTM2, GST4, GSTM, GSTM2-2, GTHMUS | glutathione S-transferase mu 2 (muscle) (EC:2.5.1.18) |
C00001518
|
2947 | GSTM3, GST5, GSTB, GSTM3-3, GTM3 | glutathione S-transferase mu 3 (brain) (EC:2.5.1.18) |
C00001518
|
2948 | GSTM4, GSTM4-4, GTM4 | glutathione S-transferase mu 4 (EC:2.5.1.18) |
C00001518
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00001518
|
2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) |
C00001518
|
2954 | GSTZ1, GSTZ1-1, MAAI, MAI | glutathione S-transferase zeta 1 (EC:2.5.1.18 5.2.1.2) |
C00001518
|
3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00001518
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00001518
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00001518
|
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00001518
|
3596 | IL13, IL-13, P600 | interleukin 13 |
C00001518
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000176
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000176
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001518
|
3684 | ITGAM, CD11B, CR3A, MAC-1, MAC1A, MO1A, SLEB6 | integrin, alpha M (complement component 3 receptor 3 subunit) |
C00001518
|
9817 | KEAP1, INrf2, KLHL19 | kelch-like ECH-associated protein 1 |
C00001518
|
9314 | KLF4, EZF, GKLF | Kruppel-like factor 4 (gut) |
C00001518
|
3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) |
C00001518
|
4067 | LYN, JTK8, p53Lyn, p56Lyn | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2) |
C00001518
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00001518
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00001518
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00000176
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00001518
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00001518
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00001518
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00001518
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00000176
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00001518
|
11315 | PARK7, DJ-1, DJ1 | parkinson protein 7 |
C00001518
|
5163 | PDK1 | pyruvate dehydrogenase kinase, isozyme 1 (EC:2.7.11.2) |
C00001518
|
5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00001518
|
5446 | PON3 | paraoxonase 3 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00001518
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001518
|
5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00001518
|
10544 | PROCR, CCCA, CCD41, EPCR | protein C receptor, endothelial |
C00001518
|
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00001071
|
55312 | RFK, RIFK | riboflavin kinase (EC:2.7.1.26) |
C00001518
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00001518
|
6415 | SEPW1, selW | selenoprotein W, 1 |
C00001518
|
9356 | SLC22A6, HOAT1, OAT1, PAHT, ROAT1 | solute carrier family 22 (organic anion transporter), member 6 |
C00001518
|
29986 | SLC39A2, 6A1, ETI-1, ZIP-2, ZIP2 | solute carrier family 39 (zinc transporter), member 2 |
C00001518
|
6520 | SLC3A2, 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE | solute carrier family 3 (amino acid transporter heavy chain), member 2 |
C00001518
|
23657 | SLC7A11, CCBR1, xCT | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
C00001518
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00001518
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00001518
|
6667 | SP1 | Sp1 transcription factor |
C00001518
|
6670 | SP3, SPR2 | Sp3 transcription factor |
C00001518
|
6671 | SP4, HF1B, SPR-1 | Sp4 transcription factor |
C00001518
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00001518
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00001518
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00001518
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00001518
|
8795 | TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9 | tumor necrosis factor receptor superfamily, member 10b |
C00001518
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00001518
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00001518
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00001518
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00000176
|
898 | CCNE1, CCNE | cyclin E1 |
C00000176
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00000176
|
486 | FXYD2, ATP1G1, HOMG2 | FXYD domain containing ion transport regulator 2 |
C00001431
|
846 | CASR, CAR, EIG8, FHH, FIH, GPRC2A, HHC, HHC1, HYPOC1, NSHPT, PCAR1 | calcium-sensing receptor |
C00001432
|
56616 | DIABLO, DFNA64, SMAC | diablo, IAP-binding mitochondrial protein |
C00001432
|
8647 | ABCB11, ABC16, BRIC2, BSEP, PFIC-2, PFIC2, PGY4, SPGP | ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
C00007247
|
1374 | CPT1A, CPT1, CPT1-L, L-CPT1 | carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) |
C00007247
|
1591 | CYP24A1, CP24, CYP24, HCAI, P450-CC24 | cytochrome P450, family 24, subfamily A, polypeptide 1 (EC:1.14.13.126) |
C00007247
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00007247
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00007247
|
3992 | FADS1, D5D, FADS6, FADSD5, LLCDL1, TU12 | fatty acid desaturase 1 (EC:1.14.19.-) |
C00007247
|
3827 | KNG1, BDK, BK, KNG | kininogen 1 |
C00007247
|
9971 | NR1H4, BAR, FXR, HRR-1, HRR1, RIP14 | nuclear receptor subfamily 1, group H, member 4 |
C00007247
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00007247
|
100136658 |
C00007247
|
||
5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta |
C00007247
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00007247
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00007247
|
7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00007247
|
26762 | HAVCR1, HAVCR, HAVCR-1, KIM-1, KIM1, TIM, TIM-1, TIM1, TIMD-1, TIMD1 | hepatitis A virus cellular receptor 1 |
C00001198
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#610251 | Alcohol sensitivity, acute |
P05091
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613780 | Aortic aneurysm, familial thoracic 7; aat7 |
Q15746
|
#609135 | Aplastic anemia |
O14746
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#600807 | Asthma, susceptibility to |
Q13093
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P42336
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#607271 | Caspase 8 deficiency |
Q14790
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
#114500 | Colorectal cancer; crc |
P18054
P42336 P84022 Q14191 |
#612918 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi |
P42336
|
#615108 | Cowden syndrome 5; cws5 |
P42336
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#246200 | Donohue syndrome |
P06213
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#613989 | Dyskeratosis congenita, autosomal dominant, 2; dkca2 |
O14746
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#612219 | Ewing sarcoma; es |
P11308
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
#232300 | Glycogen storage disease ii |
P10253
|
#612938 | Growth retardation, developmental delay, coarse facies, and early death; gdfd |
Q9C0B1
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#114550 | Hepatocellular carcinoma |
P08581
P42336 |
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#182000 | Keratosis, seborrheic |
P42336
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 Q14790 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#602501 | Megalencephaly-capillary malformation-polymicrogyria syndrome; mcap |
P42336
|
#603387 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; mpph |
P42336
|
#613839 | Megaloblastic anemia due to dihydrofolate reductase deficiency |
P00374
|
#615134 | Melanoma, cutaneous malignant, susceptibility to, 9; cmm9 |
O14746
|
#614254 | Mental retardation, autosomal dominant 8; mrd8 |
Q05586
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
P42336 |
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#604559 | Progressive familial heart block, type ib; pfhb1b |
Q8TD43
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#614742 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1; pfbmft1 |
O14746
|
#178500 | Pulmonary fibrosis, idiopathic; ipf |
O14746
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#180300 | Rheumatoid arthritis; ra |
Q9H015
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P00734
P16109 P24723 |
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#610379 | West nile virus, susceptibility to |
P51681
|
#193670 | Whim syndrome |
P61073
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00764 | Cri du chat syndrome |
O14746
(related)
|
H01132 | Aplastic anemia (AA) |
O14746
(related)
|
H01299 | Idiopathic pulmonary fibrosis |
O14746
(related)
|
H00022 | Bladder cancer |
O14746
(marker)
P00533 (related) P04626 (related) P04637 (related) |
H00024 | Prostate cancer |
O14746
(marker)
P10275 (related) P11308 (related) |
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P08581 (related) Q16790 (marker) |
H01197 | Dihydrofolate reductase (DHFR) deficiency |
P00374
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P08581 (related) P10415 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P10415 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) P10415 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) Q15046 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) P42336 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P08581 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P10415 (related) P28907 (marker) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
P10415 (related) |
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
P10415 (related) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H01071 | Acute alcohol sensitivity |
P05091
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q99700 (related) Q9NUW8 (related) |
H00213 | Hypophosphatasia |
P05186
(related)
|
H00719 | Leprechaunism |
P06213
(related)
|
H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00054 | Nasopharyngeal cancer |
P10415
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00409 | Type II diabetes mellitus |
P37231
(related)
Q9C0B1 (related) |
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00097 | Chemokine receptor defect |
P61073
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00408 | Type I diabetes mellitus |
Q04759
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00108 | Autoimmune lymphoproliferative syndromes (ALPS) |
Q14790
(related)
|
H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) |
Q15746
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H01263 | Progressive cardiac conduction defect (PCCD) |
Q8TD43
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00926 | Growth retardation, developmental delay, coarse facies, and early death |
Q9C0B1
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H00286 | Crohn's disease |
Q9H015
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D012640 | Seizures |
C00001518
C00001431 C00001432 |
D009336 | Necrosis |
C00001518
C00001432 |
D006948 | Hyperkinesis |
C00001431
C00001432 |
D058186 | Acute Kidney Injury |
C00001518
C00001198 |
D009422 | Nervous System Diseases |
C00001518
C00007247 |
D001930 | Brain Injuries |
C00001432
C00007247 |
D008569 | Memory Disorders |
C00001518
C00001432 |
D006331 | Heart Diseases |
C00001518
C00001432 |
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001518
C00007247 |
D056486 | Drug-Induced Liver Injury |
C00001518
C00001431 |
D001745 | Urinary Bladder Diseases |
C00001518
|
D002779 | Cholestasis |
C00001518
|
D003072 | Cognition Disorders |
C00001518
|
D003550 | Cystic Fibrosis |
C00001518
|
D003556 | Cystitis |
C00001518
|
D003877 | Dermatitis, Contact |
C00001518
|
D017719 | Diabetic Foot |
C00001518
|
D002294 | Carcinoma, Squamous Cell |
C00001518
|
D001321 | Autistic Disorder |
C00001518
|
D004487 | Edema |
C00001518
|
D005076 | Exanthema |
C00001518
|
D005199 | Fanconi Anemia |
C00001518
|
D005234 | Fatty Liver |
C00001518
|
D005334 | Fever |
C00001518
|
D005767 | Gastrointestinal Diseases |
C00001518
|
D000647 | Amnesia |
C00001518
|
D006417 | Hematuria |
C00001518
|
D006461 | Hemolysis |
C00001518
|
D006470 | Hemorrhage |
C00001518
|
D020138 | HYPERHOMOCYSTEINEMIA |
C00001518
|
D006973 | Hypertension |
C00001518
|
D006975 | Hypertension, Portal |
C00001518
|
D006980 | Hyperthyroidism |
C00001518
|
D007565 | Jaundice |
C00001518
|
D007674 | Kidney Diseases |
C00001518
|
D008105 | Liver Cirrhosis, Biliary |
C00001518
|
D008106 | Liver Cirrhosis, Experimental |
C00001518
|
D008113 | Liver Neoplasms |
C00001518
|
D001943 | Breast Neoplasms |
C00000176
|
D008630 | Mercury Poisoning |
C00001518
|
D008708 | Methemoglobinemia |
C00001518
|
D009069 | Movement Disorders |
C00001518
|
D009008 | Abnormalities, Severe Teratoid |
C00001518
|
D009203 | Myocardial Infarction |
C00001071
|
D020258 | Neurotoxicity Syndromes |
C00001518
|
D010051 | Ovarian Neoplasms |
C00001518
|
D010523 | Peripheral Nervous System Diseases |
C00001518
|
D005909 | Glioblastoma |
C00001071
|
D013226 | Status Epilepticus |
C00001518
|
D009202 | Cardiomyopathies |
C00001518
|
D006332 | Cardiomegaly |
C00001431
|
D002471 | Cell Transformation, Neoplastic |
C00001183
|
D011041 | Poisoning |
C00001431
|
D000740 | Anemia |
C00001432
|
D011471 | Prostatic Neoplasms |
C00000176
|
D002545 | Brain Ischemia |
C00001432
|
D007859 | Learning Disorders |
C00001432
|
D009410 | Nerve Degeneration |
C00001432
|
D014202 | Tremor |
C00001432
|
D003866 | Depressive Disorder |
C00007247
|
D007249 | Inflammation |
C00007247
|
D006959 | Hyperoxaluria |
C00001198
|
D006960 | Hyperoxaluria, Primary |
C00001198
|
D009397 | Nephrocalcinosis |
C00001198
|
D053040 | Nephrolithiasis |
C00001198
|
D051437 | Renal Insufficiency |
C00001198
|